期刊文献+

肺泡表面活性物质联合鼻塞式持续气道正压通气治疗早产儿肺透明膜病的应用研究 被引量:8

Application of pulmonary surfactant combined with nasal continuous positive airway pressure ventilation in the treatment of premature infants with hyaline membrane disease
原文传递
导出
摘要 目的分析早产儿肺透明膜病经肺泡表面活性物质联合鼻塞式持续气道正压通气治疗的效果。方法选取黄山市人民医院2014年11月-2017年11月收治的肺透明膜病早产儿50例,依据不同治疗方法分为两组,24例施予鼻塞式持续气道正压通气治疗者为对照组,26例予以肺泡表面活性物质联合鼻塞式持续气道正压通气治疗者为试验组,比较两组血气分析指标、呼吸力学与并发症发生情况。结果治疗后,试验组血氧饱和度(SpO2)、血氧分压(PaO2)、二氧化碳分压(PaCO2)、氢离子浓度指数(pH)优于对照组,且试验组呼吸时间常数(RCexp)、呼气峰流量(PEF)均较对照组高,差异均有统计学意义(P均<0.05);试验组并发症发生率为低于对照组(7.69%vs.28.00%),差异有统计学意义(P<0.05)。结论通过肺泡表面活性物质联合鼻塞式持续气道正压通气治疗早产儿肺透明病,可有效改善其血气分析指标,并提升RCexp、PEF,达到减少并发症、改善预后的效果,值得推广。 Objective To investigate the effect of alveolar surfactant combined with nasal plug continuous positive airway pressure ventilation in the treatment of pulmonary hyaline membrane disease in preterm infants. Methods Totally 50 cases treated in Huangshan People′s Hospital from November 2014 to November 2017 were enrolled in this study.The participants were divided into two groups,the control group(n=24)was given nasal continuous positive airway pressure therapy,and the experimental group(n=26)was treated with pulmonary surfactant combined with nasal continuous positive airway pressure ventilation.Blood gas analysis index,incidence of complications and respiratory mechanics of the two groups were collected and compared. Results Percutaneous oxygen saturation(SpO2),partial pressure of oxygen(PaO2),partial pressure of carbon dioxide(PaCO2)and hydrogen ion concentration(pH)in experimental group were better than those in control group after treatment(P〈0.05).Also,the levels of breathing time constant(RCexp)and peak expiratory flow(PEF)were significantly higher in the experimental group than those in the control group(P〈0.05).The complication rate of experimental group was 7.69%,which was significantly lower than that of control group(28%)(P〈0.05). Conclusion Pulmonary surfactant combined with nasal continuous positive airway pressure can effectively improve the blood gas analysis index,increase RCexp and PEF in preterm infants with pulmonary hyaline disease,thereby reducing complications and improving prognosis.
作者 章晓波 ZHANG Xiao-bo(Huangshan People's Hospital,Huangshan,Anhui 245000,Chin)
机构地区 黄山市人民医院
出处 《中国儿童保健杂志》 CAS 2018年第8期890-893,共4页 Chinese Journal of Child Health Care
关键词 早产儿 肺透明膜病 鼻塞式持续气道正压通气 肺泡表面活性物质 preterm infants hyaline membrane disease of the lung nasal continuous positive airway pressure ventilation pulmonary surfactant
  • 相关文献

参考文献10

二级参考文献90

  • 1邓睿,唐彬秩,刘华,屈艺,母得志.新生儿肺透明膜病发病及预后的高危因素分析[J].四川大学学报(医学版),2010,41(4):688-691. 被引量:16
  • 2肖巨庆,赵凤琴,张炜灵,廖华,黄艳.固尔苏治疗早产儿肺透明膜病36例疗效观察[J].中国全科医学,2005,8(18):1533-1534. 被引量:12
  • 3廖志,万朝敏,刘忠强.新生儿呼吸窘迫综合征防治的临床证据[J].中国新生儿科杂志,2007,22(1):36-38. 被引量:1
  • 4邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2011:872.
  • 5邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 6蔡春琼,吕铁伟,王孝君,等.珂立苏联合经鼻间歇性正压通气(NIPPV)治疗新生儿呼吸窘迫综合征46例临床分析[J].现代生物学进展,2012,12(30):5874.
  • 7MedjoB,Atanaskovic-MarkovicM,NikolicD,etal.Inhalednitricoxidetherapyforacuterespiratorydistresssyndromeinchildren[J].IndianPediatr,2012,49(7):573-576.
  • 8Steven MD, Jennifer D. Surfactant replacement therapy in the neo- nate :beyond respiratory distress syndrome [J]. Resp Care,2009,54 (9) :1203-1208.
  • 9RUBARTH L B,QUINN J.Respiratory Development and Respiratory Distress Syndrome[J].Neonatal Netw,2015,34(4):231-238.
  • 10ORGEIG S,MORRISON J L,DANIELS C B.Evolution,Development,and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments[J].Compr Physiol,2015,6(1):363-422.

共引文献130

同被引文献86

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部